-
1 Comment
Aurobindo Pharma Limited is currently in a long term uptrend where the price is trading 6.4% above its 200 day moving average.
From a valuation standpoint, the stock is 56.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.1.
Aurobindo Pharma Limited's total revenue rose by 7.8% to $64B since the same quarter in the previous year.
Its net income has increased by 317.7% to $29B since the same quarter in the previous year.
Finally, its free cash flow fell by 5.6% to $21B since the same quarter in the previous year.
Based on the above factors, Aurobindo Pharma Limited gets an overall score of 4/5.
ISIN | INE406A01037 |
---|---|
Exchange | NSE |
CurrencyCode | INR |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Dividend Yield | 0.0% |
---|---|
Market Cap | 649B |
Beta | 0.14 |
PE Ratio | 19.16 |
Target Price | 1293.3928 |
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin's, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for AUROPHARMA.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025